SNN Smith & Nephew plc

30.21USD+1.27%Mkt Cap: 12.47B USDP/E: 20.29

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three seg…

Institutional holders20 on file

Key Statistics

Company
Market Cap12.47B USD
Enterprise Value66.50B USD
Revenue (TTM)6.30B USD
Gross Profit4.19B USD
Net Income (TTM)625.00M USD
Revenue/Share2.95 USD
Last Price30.21 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees17.0K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)20.29
P/E (Forward)12.57
PEG1.11
EV/EBITDA48.12
EV/Revenue10.56
P/S1.98
P/B12.25
EPS (TTM)1.47 USD
EPS (Forward)2.37 USD
52W Range
26.1237% of range37.09
52W High37.09 USD
52W Low26.12 USD
Profitability
Gross Margin68.01%
Oper. Margin14.22%
EBITDA Margin21.94%
Profit Margin10.14%
ROE11.82%
ROA5.98%
ROIC8.53%
ROCE9.67%
Growth
Revenue Growth4.60%
Earnings Growth5.70%
Cash Flow & Leverage
Operating CF1.28B USD
CapEx (TTM)433.00M USD
FCF Margin16.81%
FCF Yield8.49%
Net Debt3.03B USD
Net Debt/EBITDA2.19
Net Debt/FCF2.86
Balance Sheet
Debt/Equity0.63
Current Ratio2.14
Quick Ratio1.11
Book Value/Sh2.43 USD
Cash/Share0.35 USD
Dividends
Fwd Div Rate0.79 USD
Trail. Div Rate0.40 USD
Div. Yield2.62%
5Y Avg Yield2.58%
Payout Ratio53.20%
Ex-Div DateOct 2, 2026
Pay DateNov 6, 2026
Splits
Last Split2499:1000
Split DateOct 15, 2014
Analyst Consensus
Rating2.8 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)33.19 USD
Upside (mean)+9.9%
Target Range30.90 USD – 38.00 USD
30.90+9.9% to mean38.00
# Analysts5
Ownership
Shares Out.418.11M
Float2.11B
Insiders0.04%
Institutions8.72%
Short Interest
Short Ratio3.6d
Short % Float1.05%
Short % Out.1.05%
Shares Short4.40M
Short (prev mo.)4.66M
Technical
SMA 5028.87 (+4.6%)
SMA 20030.91 (-2.3%)
Beta0.67
S&P 52W Chg12.00%
Avg Vol (30d)1.42M
Avg Vol (10d)1.58M
Technical Indicators
RSI (14)46.6
MACD0.4008
MACD Signal0.6148
MACD Hist.-0.2140
BB Upper32.11 USD
BB Middle30.73 USD
BB Lower29.35 USD
BB Width8.99%
ATR (14)0.6423 USD
Vol Ratio (20d)0.72x

About Smith & Nephew (NYSE: SNN)

›

Smith & Nephew (NYSE: SNN) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 17,000 employees.

The shares were at 30.21 USD on 20 November 2026, down 6.9% over 52 weeks. Its 52-week range is 26.12 USD to 37.09 USD: the price is 18.5% below the high and 15.7% above the low.

At a market capitalisation of 12.47B USD, it trades at 20.3 times trailing earnings and 12.6 times forward earnings. The median trailing P/E of its 18 largest Medical Devices peers is 26.3, a discount of 23% for SNN. It pays a dividend yielding 2.62% (it pays out 53% of its earnings), against a median of 1.97% among the dividend payers in that peer group.

Smith & Nephew reports return on equity of 11.8%, an operating margin of 14.2% and revenue up 4.6% year over year.

Its debt exceeds its cash by 3.03B USD, a debt-to-equity ratio of 0.63. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 5 analysts cover the stock, with an average rating of Hold; their mean price target of 33.19 USD is 9.9% above the current price. The next earnings report is expected on 1 March 2027.